A 3D rendering of a neuron
Independent FDA Advisory Panel Recommends Approving ALS Drug
The group’s 7-2 ruling in favor of the therapeutic represents a shift from previous deliberations, in which data on its effectiveness was deemed insufficient.
Independent FDA Advisory Panel Recommends Approving ALS Drug
Independent FDA Advisory Panel Recommends Approving ALS Drug

The group’s 7-2 ruling in favor of the therapeutic represents a shift from previous deliberations, in which data on its effectiveness was deemed insufficient.

The group’s 7-2 ruling in favor of the therapeutic represents a shift from previous deliberations, in which data on its effectiveness was deemed insufficient.

pharmaceuticals
Zebrafish with fluorescent nervous system in green.
Oust the Mouse: A Plan to Reduce Mammal Use in Drug Development
Natalia Mesa | Mar 15, 2022
The Scientist spoke to Mount Desert Island Biological Laboratory’s Jim Strickland about the institute’s new MDI Bioscience initiative to perform more drug testing and development in nonmammalian models.
a man collects water using a fishing pole and can
World’s Rivers Rife with Drugs: Study
Christie Wilcox | Feb 15, 2022
Levels of pharmaceuticals considered unsafe for aquatic organisms were found at more than one-quarter of sampling sites.
Discover how flow cytometry accelerates drug screening
Adapting Flow Cytometry for Drug Discovery Workflows
The Scientist Creative Services Team and Bio-Rad Laboratories
Explore how flow cytometry innovations expand and accelerate cell profiling.
Insight into Dexamethasone’s Benefits in Severe COVID-19
Abby Olena | Jun 19, 2020
The steroid’s exceptional performance in early results from the RECOVERY clinical trial in the United Kingdom is a rational outcome of the drug’s anti-inflammatory effects, experts say.
Judge Rules Unreported Clinical Trial Data Must Be Made Public
Amy Schleunes | Feb 26, 2020
The sponsors of upwards of 1,000 clinical trials may be forced to publish data that have gone unpublished over a 10-year period.
Learn about universal documentation for easy compliance testing
Simplify Laboratory Compliance with Universal Documentation
The Scientist Creative Services Team and PerkinElmer
Universal electronic documentation takes care of instrument compliance testing, allowing researchers to get back to the bench.
Biogen, Eisai End Two Late-Stage Trials for Alzheimer’s Treatment
Emily Makowski | Sep 16, 2019
The widely expected move comes months after the companies scrapped trials of another Alzheimer’s drug.
How the Brain Changes on Ketamine: A Live Animal Study
Ruth Williams | Apr 11, 2019
The drug promotes and sustains brain cell connectivity in mice, reversing the effects of chronic stress.
Clear and Easy Flowing: Analyzing Antibody Self-Interactions
Strategies for the Rapid Assessment of Antibody Self-Interactions and Improved Formulations Development
The Scientist Creative Services Team and Sartorius
Martin Domnowski explains how sequence and formulation affect antibody self-interaction properties, and how researchers detect these interactions in low concentration samples.
removing chemotheraphy drugs
Mopping Up Excess Chemotherapy Drugs
Ruth Williams | Apr 1, 2019
A prototype in-vein device would collect toxic medications before they reach healthy tissues.
the Lasker award trophy
Lasker Awards Recognize Work on Histones, Anesthesia, RNA
Shawna Williams | Sep 11, 2018
This year’s winners are C. David Allis, Michael Grunstein, John Glen, and Joan Steitz.
Learn How to Accurately Determine Protein Conformation
Focus on Structure to Verify Protein Function
The Scientist Creative Services Team and RedShift Bio
Scientists analyze a therapeutic protein’s secondary structure to confirm drug efficacy and safety.
FDA Approves First Marijuana-Derived Drug
Shawna Williams | Jun 25, 2018
As the CBD-based medication enters the market, the agency promises a crackdown on producers of cannabidiol products that make unproven claims.
Researchers Getting Smarter About Pairing Cancer Treatments
Anna Azvolinsky | Apr 1, 2018
Multidrug combinations lead to better results for cancer patients, but efficiently identifying them is proving difficult.
Detecting Subvisible Particles in Protein Therapeutics
The Scientist Creative Services Team in collaboration with Yokogawa Fluid Imaging Technologies
New flow imaging microscopy technology visualizes a broad range of subvisible particles hidden in therapeutic suspensions.  
Infographic: Cancer Drug Pairings
Anna Azvolinsky | Mar 31, 2018
Researchers use several different strategies to deliver a one-two punch.
Pfizer to Halt Alzheimer’s and Parkinson’s Drug Research
Jim Daley | Jan 7, 2018
The company’s recent effort to find new treatments for Alzheimer’s ended in disappointment.
One Size Does Not Fit All: Pharmacogenomics in Precision Medicine
The Scientist Creative Services Team
Sandosh Padmanabhan and Andrew Morrow will discuss how pharmacogenomics methods improve precision medicine for cardiovascular disease treatment.
Clinical Trial Reporting for Pharma-Sponsored Trials Shows Improvement
Diana Kwon | Dec 4, 2017
The Good Pharma Scorecard finds some big pharmaceutical companies are meeting legal standards for disclosing results—but many studies still go unreported.